PHARMACYTE BIOTECH, INC. Dividends Payable
PHARMACYTE BIOTECH, INC. (PMCB) had Dividends Payable of $1.58 thousand as of 2025-10-31, per its 10-Q filed 2025-12-18.
Financial Statements › Balance Sheet › Liabilities › Accrued Liabilities
us-gaap:DividendsPayableCurrentAndNoncurrent · last filed 2025-12-18
- 2025-10-31: Dividends Payable $1.58K.
- 2025-07-31: Dividends Payable $1.38K.
- 2025-04-30: Dividends Payable $1.58K.
| Period end | Dividends Payable |
|---|---|
| 2025-10-31 | $1.58K 10-Q · filed 2025-12-18 |
| 2025-07-31 | $1.38K 10-Q · filed 2025-09-15 |
| 2025-04-30 | $1.58K 10-Q · filed 2025-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |